Nephrology Dialysis Transplantation · 2007 · 10 citations · 7 references
MedicinePathobiologyPathologyMolecular PathologyRenal PathologyRenal PathophysiologyCongenital Renal AnomaliesGlomerular DiseasesGlomerular PathophysiologyHereditary Kidney DiseasesHereditary Renal DiseasesRenal DiseaseAlagille SyndromeApolipoprotein A-i AmyloidosisBile Duct DiseaseHereditary Glomerular DiseasesKidney Biopsy FindingsMesangial ProliferationPediatric Glomerular DiseaseRenal Biopsy Findings
Alagille syndrome (AGS) (OMIM #118450) is an inherited multiorgan disorder. Renal mesangiolipidosis was first described in this syndrome in 1982 and is characterized by enlarged glomeruli, secondary to an increase in the mesangial matrix and the presence of cells containing lipid droplets on sections stained with Sudan black [ 1 ]. The precise mechanism by which lipids are deposited in the kidneys of AGS patients is unclear. We present a case of mesangiolipidosis associated with apolipoprotein A-I (apoA-I) abnormalities in a child with a known diagnosis of AGS, leading us to consider the role of this lipoprotein in the pathogenesis of mesangial lipid deposition. During the first week of life, the patient presented with conjugated hyperbilirubinaemia and renal dysfunction. Subsequent investigations showed paucity of bile duct on liver biopsy, two small hyperechogenic kidneys, tetralogy of Fallot, dysmorphic facies and butterfly vertebrae. Diagnosis of AGS was confirmed by molecular genetic testing showing a microdeletion in JAG1 within 20p12 by fluorescence in situ hybridization (FISH) technique. During follow-up, the isotopic glomerular filtration rate (GFR), performed at 17 months of age, was 57 cc/min/1.73 m 2 (normal GFR for age: 95.7 ± 21.7 cc/min/1.73 m 2 ) and the patient had mild proteinuria up to 1 g/day. Despite treatment with ursodeoxycholic acid, chronic cholestasis and hyperlipidaemia were persistent. At 34 months of age, total bilirubin and conjugated bilirubin were increased to 690 and 420 μmol/l, respectively, while GGT was 105 U/l and INR was 1.02. Non-fasting plasma lipid levels showed an elevated plasma concentration of total cholesterol (8.57, normal 3.20–4.40 mmol/l), triglycerides (2.83, normal 0.4–1.3 mmol/l), Low-density lipoprotein (LDL)-cholesterol (7.16, normal 1.76–3.62 mmol/l) and reduced plasma concentration of High-density lipoprotein (HDL)-cholesterol (0.12, normal 0.93–1.89 mmol/l). Plasma apoA-I level was low (0.25, normal 0.94–1.78 g/l) and apolipoprotein B (apoB) level was elevated (1.83, 0.52–1.09 g/l). Progressively, serum creatinine concentration increased to 1.39 mg/dl (normal 0.26–0.61 mg/dl) and remained consistently high; a kidney biopsy was thus performed.
7
Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia)
Ren�e Habib, J.P. Dommergues, Marie-Claire Gübler et al. · Pediatric Nephrology · 1987 · 52 citations
Medicine, Nephrology, Pathology +15
Renal lipidosis associated with arteriohepatic dysplasia (Alagille's syndrome).
M Chung-Park, Mary Petrelli, Tavill As et al. · PubMed · 1982 · 29 citations
Medicine, Nephrology, Pathology +17